Showing results (351-360 of 359) with videos related to

Sort By:
Pageof 36
You have reached the last page of results.This site can display upto 359 results.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 6, 2022
First-line nivolumab plus ipilimumab versus chemotherapy in patients with unresectable malignant pleural mesothelioma: 3-year outcomes from CheckMate 743S Peters, A Scherpereel, R Cornelissen, et al.
JCI Insight|July 24, 2019
Mitochondrial fusion exploits a therapeutic vulnerability of pancreatic cancerMeifang Yu, Nicholas D Nguyen, Yanqing Huang, et al.
Cancer Research|May 3, 2019
Selective EGLN Inhibition Enables Ablative Radiotherapy and Improves Survival in Unresectable Pancreatic CancerTara N Fujimoto, Lauren E Colbert, Yanqing Huang, et al.
Scientific Reports|February 15, 2019
Enteral Activation of WR-2721 Mediates Radioprotection and Improved Survival from Lethal Fractionated RadiationJessica M Molkentine, Tara N Fujimoto, Thomas D Horvath, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|December 1, 1996
[Effect of FUT-187, oral serine protease inhibitor, on inflammation in the gastric remnant]H Shiozaki, M Inoue, S Tamura, et al.
Science Translational Medicine|November 29, 2023
Radiation-induced bone loss in mice is ameliorated by inhibition of HIF-2α in skeletal progenitor cellsWendi Guo, Jiaul Hoque, Carolina J Garcia Garcia, et al.
Gastroenterology|February 26, 2022
Stromal HIF2 Regulates Immune Suppression in the Pancreatic Cancer MicroenvironmentCarolina J Garcia Garcia, Yanqing Huang, Natividad R Fuentes, et al.
ESMO Open|November 28, 2021
Anti-PD-1 antibody monotherapy versus anti-PD-1 plus anti-CTLA-4 combination therapy as first-line immunotherapy in unresectable or metastatic mucosal melanoma: a retrospective, multicenter study of 329 Japanese cases (JMAC study)Y Nakamura, K Namikawa, S Yoshikawa, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|June 1, 1983
[Phase II study with methyl-6[[[2-chloroethyl) nitrosoamino] carbonyl] amino]-6-deoxy-alpha-D-glucopyranoside (MCNU) in hematological malignancies]T Masaoka, K Kimura, T Miyazaki, et al.
Pageof 36